Skip to Main content Skip to Navigation
Master Thesis

VIVEC : development of a group cognitive-behavioral psychotherapy for anti-depressive purposes

Abstract : Introduction: We realized a group of psychotherapy mixing two types of cognitive-behavioral therapies, whose effectiveness we observed. The primary endpoint was evolution of depressive symptomatology at 6 months. The criteria for secondary judgments were anxious symptomatology and quality of life. Methods: 19 patients, over 60 years of age, with a Mini-Mental State Examination score ≥ 24, were included (mean age = 73.85 years), successively, in the psychotherapy group and the waiting list. Patients had a history of less than one year of major depressive disorder, and / or dysthymia, and / or non-specific depressive disorder, and / or an antecedent of less than one year of anxiety disorder. Participants were required to complete pre-treatment questionnaires, at 3 months of inclusion and 6 months of inclusion. Results: There was improvement in both groups of depression, anxiety, and quality of life. The percentage improvement in depression is better in the VIVEC group. Statistical tests are not significant. Conclusion: This pilot study shows an improvement in the primary and secondary endpoints. This experience will improve future groups.
Document type :
Master Thesis
Complete list of metadata

Cited literature [83 references]  Display  Hide  Download
Contributor : Santé Rennes 1 <>
Submitted on : Monday, June 3, 2019 - 2:08:57 PM
Last modification on : Wednesday, November 11, 2020 - 12:00:07 PM


Files produced by the author(s)


  • HAL Id : dumas-02145908, version 1



Géraldine Astrié. VIVEC : development of a group cognitive-behavioral psychotherapy for anti-depressive purposes. Life Sciences [q-bio]. 2018. ⟨dumas-02145908⟩



Record views


Files downloads